Woo JS - Search Results

1

Optimization of tamsulosin hydrochloride controlled release pellets coated with Surelease and neutralized HPMCP.

Kim MS, Kim JS, Lee S, Jun SW, Park JS, Woo JS, Hwang SJ. Kim MS, et al. Among authors: woo js. J Pharm Pharmacol. 2006 Dec;58(12):1611-6. doi: 10.1211/jpp.58.12.0007. J Pharm Pharmacol. 2006. PMID: 17331324

2

Influence of water soluble additives and HPMCP on drug release from Surelease-coated pellets containing tamsulosin hydrochloride.

Kim MS, Kim JS, Kang SH, Yoo YH, Lee S, Park JS, Woo JS, Hwang SJ. Kim MS, et al. Among authors: woo js. Arch Pharm Res. 2007 Aug;30(8):1008-13. doi: 10.1007/BF02993970. Arch Pharm Res. 2007. PMID: 17879755

3

Development and optimization of a novel oral controlled delivery system for tamsulosin hydrochloride using response surface methodology.

Kim MS, Kim JS, You YH, Park HJ, Lee S, Park JS, Woo JS, Hwang SJ. Kim MS, et al. Among authors: woo js. Int J Pharm. 2007 Aug 16;341(1-2):97-104. doi: 10.1016/j.ijpharm.2007.03.051. Epub 2007 Apr 5. Int J Pharm. 2007. PMID: 17499949

4

Cefuroxime axetil solid dispersions prepared using solution enhanced dispersion by supercritical fluids.

Jun SW, Kim MS, Jo GH, Lee S, Woo JS, Park JS, Hwang SJ. Jun SW, et al. Among authors: woo js. J Pharm Pharmacol. 2005 Dec;57(12):1529-37. doi: 10.1211/jpp.57.12.0003. J Pharm Pharmacol. 2005. PMID: 16354397

5

Recrystallization of fluconazole using the supercritical antisolvent (SAS) process.

Park HJ, Kim MS, Lee S, Kim JS, Woo JS, Park JS, Hwang SJ. Park HJ, et al. Among authors: woo js. Int J Pharm. 2007 Jan 10;328(2):152-60. doi: 10.1016/j.ijpharm.2006.08.005. Epub 2006 Aug 12. Int J Pharm. 2007. PMID: 16959448

6

Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.

Jun SW, Kim MS, Kim JS, Park HJ, Lee S, Woo JS, Hwang SJ. Jun SW, et al. Among authors: woo js. Eur J Pharm Biopharm. 2007 Jun;66(3):413-21. doi: 10.1016/j.ejpb.2006.11.013. Epub 2006 Nov 29. Eur J Pharm Biopharm. 2007. PMID: 17240129

7

Preparation and characterization of solid dispersions of itraconazole by using aerosol solvent extraction system for improvement in drug solubility and bioavailability.

Lee S, Nam K, Kim MS, Jun SW, Park JS, Woo JS, Hwang SJ. Lee S, et al. Among authors: woo js. Arch Pharm Res. 2005 Jul;28(7):866-74. doi: 10.1007/BF02977355. Arch Pharm Res. 2005. PMID: 16114503

8

Enhanced oral bioavailability of paclitaxel by coadministration of the P-glycoprotein inhibitor KR30031.

Woo JS, Lee CH, Shim CK, Hwang SJ. Woo JS, et al. Pharm Res. 2003 Jan;20(1):24-30. doi: 10.1023/a:1022286422439. Pharm Res. 2003. PMID: 12608532

9

Preparation and evaluation of Cremophor-free paclitaxel solid dispersion by a supercritical antisolvent process.

Park JH, Yan YD, Chi SC, Hwang DH, Shanmugam S, Lyoo WS, Woo JS, Yong CS, Choi HG. Park JH, et al. Among authors: woo js. J Pharm Pharmacol. 2011 Apr;63(4):491-9. doi: 10.1111/j.2042-7158.2010.01218.x. Epub 2011 Mar 1. J Pharm Pharmacol. 2011. PMID: 21401600

10

Novel fenofibric acid-loaded controlled release pellet bioequivalent to choline fenofibrate-loaded commercial product in beagle dogs.

Kim KS, Jin SG, Mustapha O, Yousaf AM, Kim DW, Kim YH, Kim JO, Yong CS, Woo JS, Choi HG. Kim KS, et al. Among authors: woo js. Int J Pharm. 2015 Jul 25;490(1-2):273-80. doi: 10.1016/j.ijpharm.2015.05.059. Epub 2015 May 27. Int J Pharm. 2015. PMID: 26024820

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

617 results

Search Page

Filters